-
SICEM 2026
SICEM 2026
- Program
- Abstracts
-
Participation
Participation
- Venue
-
News & Gallery
News & Gallery
LOG IN
SIGN UP
KESScientific program
Joint symposium
-
ES-KES joint symposium
Day 2, Friday, April 10, 08:30-10:00 / Room 3(East tower 2F)
Chairpersons: Robert Lash (University of Michigan Medical School, USA), TBD
08:30-09:00
Managing osteoporosis treatment sequences with denosumab discontinuation
Elaine W. Yu (Harvard Medical School, USA)
09:00-09:30
From bone health to lifespan: Why antiresorptive therapy matters beyond fracture
prevention
Kyoung Jin Kim (Korea University, Korea)
09:30-10:00
Bone as a battleground: Anti-resorptives in cancer-related bone diseases
Gregory Clines (University of Michigan, USA)
-
Rising stars in endocrinology
Day 3, Saturday, April 11, 08:30-10:00 / Room 2(West tower B1F)
Chairpersons : Jenny Gunton (University of Sydney, Australia), TBD
08:30-08:50
Immune checkpoint inhibitor-related endocrine dysfunction
Tomoko Kobayashi (Nagoya University, Japan)
08:50-09:10
Shifting paradigms in Graves' disease and thyroid eye disease: Towards
disease-modifying strategies
Chia-Hung Lin (National Taiwan University, Taiwan)
09:10-09:30
From snapshot to movie: The evolution of fracture risk assessment
Sung Hye Kong (Seoul National University, Korea)
09:30-09:50
Rebound phenomenon after denosumab: Translational insights into prevention
Albert Sungsoo Kim (University of Sydney, Australia)
09:50-10:00
Q&A
-
PCEDM-KES joint symposium
Practical approach in treatment of endocrine diseases
Day 3, Saturday, April 11, 14:50-16:20 / Room 4(East tower 2F)
Chairpersons : Lora May T. Tin Hay (President of PCEDM, Philippines), TBD
14:50-15:20
Sequential therapy in osteoporosis: When, how and for whom?
Monica Therese Cating-Cabral (Philippine College of Endocrinology, Diabetes and Metabolism, Philippines)
15:20-15:50
Subclinical hypothyroidism in real-world practice: Whom to treat and how to
monitor?
Jeongmin Lee (The Catholic University of Korea, Korea)
15:50-16:20
Newer antidiabetic agents in daily clinical practice: When and how to use
Wonjin Kim (CHA University, Korea)
- ES-KES joint symposium Day 2, Friday, April 10, 08:30-10:00 / Room 3(East tower 2F)
Chairpersons: Robert Lash (University of Michigan Medical School, USA), TBD
|
|
08:30-09:00 | Managing osteoporosis treatment sequences with denosumab discontinuation Elaine W. Yu (Harvard Medical School, USA) |
|
|
09:00-09:30 | From bone health to lifespan: Why antiresorptive therapy matters beyond fracture prevention Kyoung Jin Kim (Korea University, Korea) |
|
|
09:30-10:00 | Bone as a battleground: Anti-resorptives in cancer-related bone diseases Gregory Clines (University of Michigan, USA) |
- Rising stars in endocrinology Day 3, Saturday, April 11, 08:30-10:00 / Room 2(West tower B1F)
Chairpersons : Jenny Gunton (University of Sydney, Australia), TBD
|
|
08:30-08:50 | Immune checkpoint inhibitor-related endocrine dysfunction Tomoko Kobayashi (Nagoya University, Japan) |
|
|
08:50-09:10 | Shifting paradigms in Graves' disease and thyroid eye disease: Towards disease-modifying strategies Chia-Hung Lin (National Taiwan University, Taiwan) |
|
|
09:10-09:30 | From snapshot to movie: The evolution of fracture risk assessment Sung Hye Kong (Seoul National University, Korea) |
|
|
09:30-09:50 | Rebound phenomenon after denosumab: Translational insights into prevention Albert Sungsoo Kim (University of Sydney, Australia) |
| 09:50-10:00 | Q&A |
-
PCEDM-KES joint symposium
Practical approach in treatment of endocrine diseases Day 3, Saturday, April 11, 14:50-16:20 / Room 4(East tower 2F)
Chairpersons : Lora May T. Tin Hay (President of PCEDM, Philippines), TBD
| 14:50-15:20 | Sequential therapy in osteoporosis: When, how and for whom? Monica Therese Cating-Cabral (Philippine College of Endocrinology, Diabetes and Metabolism, Philippines) | |
|
|
15:20-15:50 | Subclinical hypothyroidism in real-world practice: Whom to treat and how to monitor? Jeongmin Lee (The Catholic University of Korea, Korea) |
| 15:50-16:20 | Newer antidiabetic agents in daily clinical practice: When and how to use Wonjin Kim (CHA University, Korea) |
- Korean Endocrine Society
-
101-2503, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
T. +82-2-714-2428 | E. endo@endocrinology.or.kr | W. www.endocrinology.or.kr
Business Registration Number: 106-82-31113 | Name of Representative : Eun-Gyoung Hong
- SICEM 2026 Secretariat (INTO-ON)
-
4F, A-Block, Richensia, 341, Baekbeom-ro, Yongsan-gu, Seoul 04315, Republic of Korea
T. +82-2-2285-2582 | E. sicem2026@into-on.com | W. www.into-on.com
- 전체 방문자 수 : 65350 명
- 금일 방문자 수 : 480 명
Copyright ⓒ The Korean Endocrine Society. All rights Reserved